Article by Anthony Wile, Huffington Post
Today’s Canadian cannabis industry is extremely confused. The Trudeau Government is in the midst of constructing regulations to be rolled out next year for recreational — or, more accurately, adult non-medicinal purpose — cannabis.
In the current legal grey zone, corner stores calling themselves dispensaries have sprung up seemingly everywhere, dispensing “medicinal cannabis” and advice to adult “patients,” as if they’re actually trained and authorized to do so, under the auspices that Canadians have a right to access that is not being sufficiently fulfilled by licensed producers.
In a nutshell, all cannabis industry stakeholders are experiencing a great deal of uncertainty as to exactly what the future Canadian cannabis production and distribution marketplace will look like.
One thing is very clear, however, even in this muddled construction zone: Ultimately, the marketplace will be defined as regulators decide, with input from special interest groups — large distributors like pharmacies and liquor control boards, the Canadian Medical Association, the Canadian Pharmacists Association etc. — that have influence in helping to shape the law in their desired direction. Let’s face it — that’s just how this works.
Early in this process of drawing up the blueprint for regulatory remodel, the federal government appointed the Task Force on Marijuana Legalization and Regulation. The Task Force began by soliciting input from Canadian stakeholders, including consumers, producers, community groups and agencies, physicians, pharmacists and others. The 30,000 submissions received are now being considered, according to Task Force leader Anne McLellan, as final recommendations are prepared, which must be submitted by November 30.